Abstract
Infections in patients with hematopoietic stem cell transplantation (HSCT) continue to remain a formidable challenge for transplanters, caregivers, and patients. The problem has been exacerbated in recent years due to the emergence of multidrug-resistant (MDR) pathogens especially among bacteria. Despite the many obvious developments in diagnostic technology and infection control practices, morbidity, mortality, and cost of care remains high due to infections in the setting of HSCT. Molecular methods in diagnosis of pathogens, improvement in infection prevention and control practices, and better use of antimicrobial therapy and prophylaxis based on pharmacokinetic-pharmacodynamic considerations and immunizations have improved outcome among HSCT patients, but a lot more remains to be achieved. Some unanswered queries persist, for example, the value of surveillance microbiology-based empirical antimicrobial therapy; the absence of decolonization therapy for MDR Gram-negative bacilli; and the role of host microbiome in influencing predilection, course, or outcome in infections. The current chapter provides a summary of the existing literature and attempts to elicit the standard of practice in the management of patients with regard to infections in the HSCT scenario.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baddley JW, Stroud TP, Salzman D, Pappas PG (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 32(9):1319–1324
Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JH, Auletta J, Komanduri KV, Lindemans C, Riches ML (2016) Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 22(9):1636–1645
Basu D, Bhattacharya S, Mahajan A, Ramanan VR, Chandy M (2014) The importance of the central sterile supply department in infection prevention and control. Infect Control Hosp Epidemiol 35(10):1312–1314
Basu S, Goel G, Bhattacharya S (2015) Infection prevention in transfusion practice. Infect Control Hosp Epidemiol 36(5):613–614
Bennett Z, Dhar R, Dhar K, Das K, Harishankar A, Bhattacharya S, Chandy M (2019) The economics of managing tuberculosis in cancer patients in an oncology center in eastern India. Infect Control Hosp Epidemiol 40(1):122–124
Bhalchandra R, Chandy M, Ramanan VR, Mahajan A, Soundaranayagam JR, Garai S, Bhattacharya S (2014) Role of water quality assessments in hospital infection control: experience from a new oncology center in Eastern India. Indian J Pathol Microbiol 57(3):435–438
Bhalchandra R, Bhattacharya S, Soundaranayagam JR, Garai S, Chandy M (2015) Importance of air particle counts in hospital infection control: insights from a cancer center in Eastern India. Infect Control Hosp Epidemiol 36(9):1115–1117
Bhattacharya S (2013) Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment? Virulence 4(2):172–184
Bhattacharya S, Goel G, Mukherjee S, Bhaumik J, Chandy M (2015) Epidemiology of antimicrobial resistance in an oncology center in Eastern India. Infect Control Hosp Epidemiol 36(7):864–866
Bhattacharya S, Dhar K, Ghosh T, Das S (2018) Chapter 35 Utility of bacterial surveillance culture in the intensive care unit for choosing empirical antibiotic therapy. In: Todi SK, Zirpe K, Kulkarni AP, Mehta Y (eds) Critical care update 2018. Indian Society of Critical Care Medicine. Jaypee Brothers Medical Publishers, New Delhi, pp 167–170
Chandy M, Bhattacharya S, Chawla T (2017) Antimicrobial Guidelines for prophylaxis and treatment of Infections in Bone Marrow Transplant settings. In: ICMR guideline on: treatment guidelines for antimicrobial use in common syndromes. Indian Council of Medical Research, Department of Health Research, New Delhi, pp 20–32. http://www.icmr.nic.in/guidelines/treatment%20guidelines%20for%20antimicrobial.pdf
Chandy M, Das A, Bhattacharyya A, Banerjee S, Dhar K, Goel G, Bhattacharya S (2018) Colistin-resistant klebsiella infections among pediatric oncology and hematopoietic stem cell transplantation patients in Eastern India. Infect Control Hosp Epidemiol 39(1):118–121
Das S, Roy S, Roy S, Goel G, Walia K, Mukherjee S, Bhattacharya S, Chandy M (2019) Rapid and economical detection of eight carbapenem-resistance genes in Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. directly from positive blood cultures using an internally controlled multiplex-PCR assay. Infect Control Hosp Epidemiol 40(6):737–739
Devasia AJ, Mammen S, Korula A, Abraham A, Fouzia NA, Lakshmi KM, Abraham AM, Srivastava A, Mathews V, George B (2018) A low incidence of cytomegalo virus infection following allogeneic hematopoietic stem cell transplantation despite a high seroprevalence. Indian J Hematol Blood Transfus 34(4):636–642
Dropulic LK, Jones RJ (2008) Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 41(1):11–18
Goel G, Chandy M, Bhattacharyya A, Banerjee S, Chatterjee S, Mullick S, Sinha S, Sengupta K, Dhar K, Bhattacharya S, Rudramurthy S, Chakrabarti A (2017) Mortality associated with candidemia in non-neutropenic cancer patients is not less compared to a neutropenic cohort of cancer patients. Eur J Clin Microbiol Infect Dis 36(12):2533–2535
Hoenigl M, Strenger V, Buzina W, Valentin T, Koidl C, Wölfler A, Seeber K, Valentin A, Strohmeier AT, Zollner-Schwetz I, Raggam RB, Urban C, Lass-Flörl C, Linkesch W, Krause R (2012) European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother 67(8):2029–2033
Jarque I, Salavert M, Pemán J (2016) Parasitic infections in hematopoietic stem cell transplantation. Mediterr J Hematol Infect Dis 8(1):e2016035
John MJ, Mathew A, Bhat S, Prabhakaran A, George B, John J (2018) Post stem cell transplantation revaccination: a survey of the current practices in India. Vaccine 36(16):2176–2180
Kumar M, Roychowdhury M, Kumar J, Harishankar A, Sinha S, Bhave SJ, Chakrapani A, Radhakrishnan V, Nair R, Bhattacharya S, Chandy M (2018) Cytomegalovirus reactivation and disease amongst patients with allogeneic haematopoietic stem cell transplantation in Eastern India: epidemiology, outcome and healthcare cost. Indian J Med Microbiol 36(1):49–53
Loren AW, Porter DL, Stadtmauer EA, Tsai DE (2003) Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31(3):145–155
Muennichow CE, Goel G, Bhattacharyya A, Nair R, Chandy M, Bhattacharya S (2018) Clinical outcome, healthcare cost and length of hospital stay among patients with bloodstream infections and acute leukemia in a cancer center in Eastern India. Infect Control Hosp Epidemiol 39(8):1021
Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, Kamble RT, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, Kasow KA, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, Page KM, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, Beitinjaneh AM, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, Ahmed IA, Schouten HC, Liesveld JL, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR (2019) Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 25(2):362–368
Roychowdhury M, Kumar J, Chakrapani A, JayantBhave S, Krishnan S, Thambudorai R, Bhattacharya S, Chandy M (2016) Low incidence of central venous catheter-related bloodstream infections in stem cell transplant patients in Eastern India despite high community burden of multidrug-resistant pathogens. Infect Control Hosp Epidemiol 37(5):619–620
Shang J, Wang H, Sun J, Fan Z, Huang F, Zhang Y, Jiang Q, Dai M, Xu N, Lin R, Liu Q (2016) A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience. Bone Marrow Transplant 51(4):581–586
Wilkin A, Feinberg J (1999) Pneumocystis carinii pneumonia: a clinical review. Am Fam Physician 60(6):1699–1708
Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH (2013) Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 48(9):1218–1223
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
George, B., Bhattacharya, S. (2021). Infections in Hematopoietic Stem Cell Transplantation (HSCT) Patients. In: Chandy, M., Radhakrishnan, V.S., Sukumaran, R.K. (eds) Contemporary Bone Marrow Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-030-36358-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-36358-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36357-4
Online ISBN: 978-3-030-36358-1
eBook Packages: MedicineReference Module Medicine